{
    "organizations": [],
    "uuid": "b10e3eb272fe29120f61d27dc40ceede244660e7",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-al-kindi-for-production-of-veterin/brief-al-kindi-for-production-of-veterinary-vaccines-drugs-q1-surplus-rises-idUSFWN1S2077",
    "ord_in_thread": 0,
    "title": "BRIEF-Al Kindi For Production Of Veterinary Vaccines Drugs Q1 Surplus Rises",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 25 (Reuters) - AL KINDI FOR PRODUCTION OF VETERINARY VACCINES DRUGS:\n* Q1 NET SURPLUS 82.9 MILLION DINARS VERSUS 1.2 MILLION DINARS YEAR AGO\n* Q1 REVENUE 322.5 MILLION DINARS VERSUS 149.1 MILLION DINARS YEAR AGO Source:( bit.ly/2HoWL3K ) Further company coverage:\n ",
    "published": "2018-04-25T15:00:00.000+03:00",
    "crawled": "2018-04-26T21:02:09.002+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "al",
        "kindi",
        "production",
        "veterinary",
        "vaccine",
        "drug",
        "q1",
        "net",
        "surplus",
        "million",
        "dinar",
        "versus",
        "million",
        "dinar",
        "year",
        "ago",
        "q1",
        "revenue",
        "million",
        "dinar",
        "versus",
        "million",
        "dinar",
        "year",
        "ago",
        "source",
        "company",
        "coverage"
    ]
}